e7 Health offers PCR COVID test results in 2 hours or less, perfect for event-goers, travelers

Schedule a drive-up appointment and receive same-day results online

We are seeing an increase in travelers as well as events in Las Vegas requiring the COVID-19 vaccine or a PCR test.”

— Jonathan Baktari, MD

LAS VEGAS, NV, US, October 20, 2021 /EINPresswire.com/ — In need of a negative COVID-19 test to travel internationally? Need one to get into a concert or event? Thanks to e7 Health, Las Vegas residents and visitors can receive results for a PCR COVID-19 test, the highest standard in COVID testing, in just two hours.

The COVID-19 PCR nasal swab test administered by e7 Health has been approved for Emergency Use Authorization (EUA) by the FDA.

“Generally, with PCR tests, clinics are going to produce results within 24-72 hours. We’ve wanted to stay on the cutting edge of COVID testing since day one, and we’re now offering an FDA-authorized PCR test with results in a fraction of that time,” said Dr. Jonathan Baktari, MD, CEO of e7 Health.

The e7 clinics are also getting calls from some clients who need a PCR COVID-19 test after realizing they had taken another type of test that wouldn’t suffice for an event, travel or another situation. Since e7 Health’s locations are near the Strip, they can schedule tests almost immediately and get results sometimes in as little as 45 minutes.

“We are seeing an increase in travelers as well as events in Las Vegas requiring the COVID-19 vaccine or a PCR test,” Dr. Baktari added. “Most of our travelers are returning to Canada or traveling on international flights to countries requiring a test. Events such as Life is Beautiful and iHeart Radio required testing, and we see that trend continuing.”

Amanda Ellis, e7’s client relationship manager, also said it’s common for both locals and travelers alike to sometimes accidentally overlook guidance on events and call the clinics last minute for help.

“A lot of times people may not pay attention to what organizers have posted or they don’t see the information on the ticket,” Ellis said. “We’re able to help them out so they can enjoy the event.”

Same-day appointments are available. Since all of e7 Health’s testing is done in-house, there are no delays with results, which are sent electronically so you can access them on mobile devices from anywhere. The test results also include a QR code, which is required by some airlines.

e7 has partnered with numerous Las Vegas Strip resorts, whose customer-facing staff inform visitors the tests are available. At the same time, e7 has expanded hours to accommodate a growing volume of patients.

The testing process is simple: Purchase your test online at e7health.com or call 702-800-2723, and arrive for your scheduled test collection from your vehicle.

e7 Health has two Las Vegas locations: 500 E. Windmill Lane, Suite. 155 & 2051 N. Rainbow Boulevard., Suite. 100.

For more information, visit
e7health.com/express-same-day-covid-19-pcr-testing

***

MORE ABOUT e7 HEALTH
e7 Health is a preventative health and wellness company supervised by board-certified doctors.

e7 Health provides seven sectors of preventive medical care in the convenience of a one-stop clinic and has pioneered an array of wellness programs that combine the latest in wellness medicine with advanced software technology.

Its proprietary-owned and -developed suite of software systems allow it to leverage technology to provide cutting-edge medical care while providing efficiencies and cost-savings for its clients.

For more information, call 702-800-2723 or visit e7health.com.

Ruth Furman
ImageWords Communications
email us here


Source: EIN Presswire

Diversify by Design latest initiative brings together Delta Dental and San Francisco State University

Delta Dental + SFSU partner in a DXD Intensive

We can’t continue to ignore the barriers these students face and expect to achieve the diversity, let alone the equity, we’re all calling for in the design field.”

— Gordon Baty, Head of User Experience Delta Dental

NEW YORK, NEW YORK, USA, October 20, 2021 /EINPresswire.com/ — The Diversify by Design (DxD) coalition launched the first collaboration within its Intensives program on October 19th, bringing together professional designers from Delta Dental and second-year students from San Francisco State University’s School of Design (HSI and AANAPISI) to address actual customer need.

With the goal of transforming the design industry by recognizing and addressing the extraordinary racial disparities within the field, DxD focuses on five critical, interconnected aspects of the design ecosystem: youth exposure, education, experience, employment, and empowerment throughout — in an effort to break down racial inequities, building and expand opportunities for people of color in the profession.

DxD Intensives creates and supports collaborations between industry partners and design programs at institutions of higher learning that serve historically excluded students, and is just one of the initiatives DxD has developed to address the lack of diversity that spans the design industry.

A significant challenge faced by many design programs serving Black and Brown students is a lack of industry partnership opportunities, creating critical gaps in tangible experience and limiting crucial networking, internship, and employment opportunities. This dynamic, in turn, impacts industry, whose systemic structures have historically supported hiring practices that have contributed to the lack of a diverse design talent pool and hindered efforts to diversify staff and create the inclusive environments that will ultimately attract and retain a diverse workforce.

DxD Intensive is beginning to bridge these gaps, offering the students industry experience that hones their critical thinking, teamwork, and collaboration skills; helps build their portfolios; and connects them to career designers, establishing those all-important initial threads of a network, while also giving industry the long overdue and much needed opportunity to embrace diverse perspectives and create inclusive environments.

“DxD Intensive is an intentional shift in the systemic dynamics within industry.” says Delta Dental’s Head of User Experience, Gordon Baty. “Our goal is to create a pattern interrupt by providing industry partnerships that will give students the access, experience, and connections they need to secure a career in their chosen field. We can’t continue to ignore the barriers these students face and expect to achieve the diversity, let alone the equity, we’re all calling for in the design field.”

SFSU’s Director of Design Programs, Mari Hulick shared a similar sentiment, “DxD and Delta Dental are not only aware of the challenges that students coming from Minority Serving Institutions face along their design paths, they are also hyper aware that their business will be more sustainable, profitable, and vibrant by creating a more diverse and inclusive workforce. They’re taking the essential first steps to level the field with DxD Intensives.”

DxD is a coalition effort of Impact Collaborative, a woman-founded social impact consulting firm. For more information on DxD or DxD Intensives, email info@dxd.design.

###

Christina DeSantis
Diversify by Design
+1 917-379-2622
email us here


Source: EIN Presswire

R3 Stem Cell Mexico Completes Buildout of New Larger Tijuana Clinic to Satisfy Increasing Demand

Stem Cell Therapy in Pakistan

Stem Cell Mexico

R3 Mexico Waiting Room

Stem Cell Mexico

R3 Mexico Treatment Room

Best Stem Cell Clinic Canada

best stem cell Mexico

R3 Stem Cell Mexico recently completed the buildout for a larger Tijuana clinic to satisfy increasing demand. The clinic features first rate treatment rooms.

Patients receive highest quality of stem cells with protocols that are safe and effective. Over 40% of our patients come from repeats and referrals, which says a ton about how patients feel about us!”

— CEO David Greene, MD, PhD, MBA

TIJUANA, BAJA CALIFORNIA, MEXICO, October 20, 2021 /EINPresswire.com/ — R3 Stem Cell Mexico recently completed the buildout for a larger Tijuana stem cell clinic to satisfy increasing demand. Despite Covid border restrictions, the clinic volume has consistently increased due to stellar outcomes and extremely cost effective pricing.

The new clinic features biometric security, first rate waiting area, large treatment rooms and a procedure room with image guidance and anesthesia equipment. With the buildout, up to ten patients are able to be accommodated simultaneously. Cushioned, reclining chairs line the treatment room, with a large screen television showing R3's Masterclass educational series.

The procedure room is private, with contemporary equipment to offer patients image guided injections, along with intrathecal and epidural procedures as well with R3's expert providers. Over fifty different conditions are successfully treated at R3 Stem Cell Therapy Mexico, with over twenty different treatment protocols in place.

According to R3 Founder/CEO David Greene, MD, PhD, MBA, "Our business model has made us the leader in Mexico stem cell therapy. Patients receive the highest quality and quantity of stem cells possible, with customized treatment protocols that are very safe and extremely effective, both clinically and cost-wise. Over 40% of our patient base now comes from repeat patients and referrals, which says a ton about how patients feel about us!"

Recently, R3 Stem Cell introduced the IntelliCell. This "smart stem cell" is a result of years of research and development, choosing the mesenchymal stem cels that are the most potent and pure possible.

The patient experience at R3 Stem Cell Mexico is first rate, with VIP escort transportation included from San Diego to the clinic and back. Also, patients receive discounts on hotels, free refreshments and also a free PRP procedure when over 50 million stem cells are purchased. In addition, any patient purchasing over 50 million stem cells also receives a complimentary vial of exosomes too.

All patients need a free consultation with one of R3's expert stem cell doctors to determine candidacy. Prospective patients should call +1 (888) 988-0515 or email info@r3stemcell.com to set it up.

David Greene, MD, PhD, MBA
R3 Stem Cell International
+1 888-988-0515
email us here


Source: EIN Presswire

Stuart Kaplan, Wins Best of Los Angeles Award- “Best Dermatologist – 2021”

“We're honored to include Stuart Kaplan into our BoLAA family.” ~Aurora DeRose

LOS ANGELES, CALIFORNIA, UNITED STATES , October 20, 2021 /EINPresswire.com/ — Stuart Kaplan, acclaimed dermatologist, wins Best of Los Angeles Award- "Best Dermatologist – 2021", according to Aurora DeRose, award coordinator for the Best of Los Angeles Award community.

The "Best of Los Angeles Award" community was formed four years ago and consists of over 7,600 professional members living and working in Southern California. It celebrates the best people, places, and things in Los Angeles with the slogan "No Ads. No B.S. Only the Best."

"The mission of the community is to celebrate the best of Los Angeles and allow its community members to connect with other members who share the highest standards of quality and integrity," expresses DeRose. "We're honored to include Stuart Kaplan into our BoLAA family."

Dr. Stuart Kaplan is a dermatologist in Beverly Hills, California. His expertise in the field has made him a leading dermatologists in the nation. This has also earned him worldwide recognition as a Skincare Authority. He is affiliated with multiple hospitals, including UCLA Medical Center and VA Greater Los Angeles Healthcare System. He received his medical degree from Albert Einstein College of Medicine and has impressively been in practice now for over than 30 years.

Due to his continuous passion and drive for dermatology, Kaplan created his line of skincare products, Kaplan M.D. Kaplan M.D. is a successful skincare line, which is clinically proven to prevent and treat different types of skin aging. Every product contains no less than ten active ingredients, including a restorative blend of patented peptides, amino acids, and vitamins.

His work has earned him awards from the American Cancer Society, American Medical Association, the United States Congress, as well as a seat on the reputable UCLA Scientific Advisory Board.

Aurora DeRose
Boundless Media Inc.
+1 951-870-0099
email us here


Source: EIN Presswire

MicroVascular Tissues Announces Peer-Reviewed Publication of Positive HIFLO Clinical Trial Results Using mVASC® Graft

Data on Nonhealing Wagner 1 & 2 Neuropathic Diabetic Foot Ulcers Published in IWJ. Additional Data to be Presented at Upcoming 2021 SAWC and DFCon Meetings.

SAN DIEGO, CA, UNITED STATES, October 20, 2021 /EINPresswire.com/ — MicroVascular Tissues, Inc., (MVT), a regenerative tissue company, today announced that the results of its HIFLO Trial assessing patient outcomes after treatment with mVASC® Microvascular Tissue Graft product have been published in an article entitled, “Improved Healing of Chronic Diabetic Foot Wounds in a Prospective Randomized Controlled Multicenter Clinical Trial with a Microvascular Tissue Allograft” in the International Wound Journal (IWJ), one of the preeminent journals aimed at improving patient care in the wound care industry.

The HIFLO trial was a Level 1, prospective, single-blind, randomized clinical trial conducted at six U.S. sites that assessed outcomes in 100 subjects with nonhealing Wagner grade 1 and 2 neuropathic diabetic foot ulcers (DFUs). The primary endpoint was the percentage of ulcers healed within 12 weeks. Secondary and research endpoints included wound area percent reduction, time to healing, improvement in blood flow (perfusion) and peripheral neuropathy.

As reported in IWJ, weekly application of mVASC resulted in significantly increased complete wound closure, greater percent wound area reduction, decreased time to healing, and improved local neuropathy compared to the control arm. The trial found that mVASC treatment increased the odds of healing by 9X. Exploratory results suggest that increased wound site perfusion and reduction of regional neuropathy accompanied wound resolution accelerated by mVASC. Taken together, these findings support the utility of microvascular tissue to restore a functional microcirculation as a new approach to treating chronic DFUs.

The HIFLO Trial’s principal investigator, Lisa Gould, M.D., Ph.D., past-president of the Wound Healing Society and lead author on the paper, commented, “My co-authors and I are delighted that with the publication of our manuscript in IWJ, additional details of the HIFLO trial have now been shared with our colleagues in the wound care community. The fact that mVASC significantly outperformed the robust standard of care treatment speaks to the potential of microvascular tissue therapy to benefit this challenging patient population.” Glen Gong, CEO of MicroVascular Tissues, added “mVASC represents a unique and highly effective vascular solution for vascular deficiencies such as neuropathic diabetic foot ulcers.”
The company announced that it will be participating in two upcoming translational meetings, the Diabetic Foot Conference (DFCon) 2021, taking place on Oct. 21-23, and the Symposium on Advanced Wound Care (SAWC) Fall 2021 meeting, to be held Oct. 29-31. At both conferences, clinical posters reporting additional results on the novel exploratory perfusion and neuropathy endpoints as well as detailing the minimization of bias in the HIFLO Trial will be presented.

About mVASC® Microvascular Tissue Graft
mVASC is a ready to use, off-the-shelf human microvascular tissue graft containing small blood vessels, extracellular matrix, and inherent biological factors. It is lyophilized, terminally sterilized, and stable at room temperature for five years. mVASC is marketed in accordance with FDA HCT/P regulations and is restricted to homologous use for the repair, reconstruction, replacement or supplementation of microvascular tissues.

About MicroVascular Tissues
MicroVascular Tissues, Inc. (MVT), is the leader in Microvascular Tissue Science. MVT is an evidence-based regenerative tissue company developing and commercializing products that address vascular deficiencies using vascular solutions, including mVASC, an allogeneic structural microvascular tissue graft product. For more information, visit www.mvtissues.com.

Doug Arm
MicroVascular Tissues, Inc.
+1 858-522-0633
darm@mvtissues.com


Source: EIN Presswire

The Healthcare Sector Is Likely To Open New Avenues of Growth of Operating Room Equipment Market

Sales of Movables Imaging Systems Operating Room Equipment to Gain Significant Revenue in Global Operating Room Equipment Market

UNITED STATES, October 20, 2021 /EINPresswire.com/ — Operating Room Equipment Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Operating Room Equipment insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. Specific factors/parameters are considered related to the individual Operating Room Equipment market and quantified with insightful rationale.

Increasing prevalence of diseases across the globe is generating huge demand for advanced healthcare system. As a result, more and more technologically advanced medical devices are being employed to aid medical Practitioners and professionals in medical setups. Sales of Operating Room Equipment devices are soaring rapidly.

The Demand analysis of Operating Room Equipment Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Operating Room Equipment Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):- https://www.factmr.com/connectus/sample?flag=S&rep_id=192
What are the Key Challenges in the Global Operating Room Equipment Market?
• Operating room equipment for use in surgical procedures are just one-time sales which may slowdown the overall market growth, making it difficult for manufacturers in operating room equipment industry to generate revenues and increase profits.
• High costs associated with operating room equipment are limiting their adoption, especially in low-income economies, creating a hindrance in the market growth.
• Although North America represents a strong outlook for operating room equipment market, unfavorable healthcare reforms in the United States will possibly pose as a potential threat to the market expansion.

The Market survey of Operating Room Equipment offers a comprehensive analysis of diverse features, including production capacities analysis of Operating Room Equipment, demand, product developments, revenue generation, and Size of Operating Room Equipment Market across the globe.

Some Notable Offerings by Fact.MR Report on Operating Room Equipment market:
• We will provide you an analysis of the extent to which this Operating Room Equipment market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
• We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
• Also, this report will help you to identify any trends to forecast growth rates.
• The analyzed report will forecast the general tendency for supply and demand.

Report Benefits & Key Questions Answered
• Operating Room Equipment Category and segment level analysis: Fact MR offers detailed analysis of the factors influencing the sales prospect across key segments. Operating Room Equipment category analysis provides deep insights into customer experiences, emerging trends and growth drivers. The vital information highlighted in this section will enable market players to make timely business decision to gain competitive advantage.
• Operating Room Equipment manufacturing trend analysis: A key aspect of the study is comprehensive Operating Room Equipment manufacturing trend analysis. These insights provide vital information on how market players are coping with latest trends that are prevailing in the market.
• Innovation and acquisition activity in Operating Room Equipment: The report highlights in detail the various organic and inorganic strategies adopted manufacturers in order to gain a competitive edge in Operating Room Equipment market. Adoption of various technologies are being discussed in detail.
• Operating Room Equipment demand by country: The report forecasts the country wise demand for Operating Room Equipment between 2021 and 2031. By analyzing this section of the report, Operating Room Equipment manufacturers can accordingly invest in those regions where the demand is on the rise.
• Post COVID consumer spending on Operating Room Equipment: The Fact.MR market survey also highlights the impact of COVID-19 on medical devices industry. These insights provide vital information on how market players are executing their manufacturing strategies to coup with the COVID-19 pandemic.

Need more information about Report Methodology? Click here:- https://www.factmr.com/connectus/sample?flag=RM&rep_id=192

Some of the Operating Room Equipment Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:
• Details regarding latest innovations and development in Operating Room Equipment and how it is gaining customer traction during the forecast period.
• Analysis about the customer demand of the products and how it is likely to evolve in coming years.
• Latest regulations enforced by government bodies and local agencies and their impact on Demand of Operating Room Equipment Market.
• Insights about adoption of new technologies and its influence on the Operating Room Equipment market Size.
• Overview of the impact of COVID-19 on Operating Room Equipment Market and economic disruptions caused by the pandemic.
• Evaluates post-pandemic impact on the Sales of Operating Room Equipment Market during the forecast period.

After reading the Market insights of Operating Room Equipment Report, readers can:
• Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
• Analyze key regions holding significant share of total Operating Room Equipment market revenue.
• Study the growth outlook of Operating Room Equipment market scenario, including production, consumption, history and forecast.
• Learn consumption pattern and impact of each end use & supply side analysis of Operating Room Equipment market.
• Investigate the recent R&D projects performed by each market player & competitive analysis of Operating Room Equipment Market Players.

Operating Room Equipment Market – Competitive Landscape
• In March 2019, Getinge AB launched an updated version of its mechanical ventilator – Servo-u 4.0, with personalized lung protection and transpulmonary pressure monitoring functions to simplify complex procedures for clinicians and simultaneously make it safer for patients.
• In March 2019, Stryker Corporation completed its acquisitions of OrthoSpace, Ltd, a privately held Israel-based company. According to Stryker, the acquisition will be highly complementary to its existing portfolio and aligns with the company’s focus to invest in sports medicine.
• In December 2018, Steris Plc, a leading player in operating room equipment market, announced its targeted reconstructing plan, including the closure of two manufacturing facilities in England and Brazil and other actions. With reduced demand for certain products, the company aims to rationalize select product offerings and consolidate manufacturing of other products.

Other leading players in the operating room equipment market include Hill-Rom Holdings, Inc., General Electric Company, KARL STORZ GmbH & Co. KG, Mizuho OSI, Inc., Medtronic, plc, Koninklijke Philips N.V., and Dragerwerk AG & Co. KGaA.

To get all-in insights on the regional landscape of the Operating Room Equipment Market, Buy Now:- https://www.factmr.com/checkout/192

More Related Reports by Fact.MR on Healthcare Sector:

• Veterinary Endodontics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031: https://www.factmr.com/report/veterinary-endodontics-market

• Therapeutic Support Surface Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031: https://www.factmr.com/report/therapeutic-support-surface-market

• Computer-Assisted Orthopedic Surgery Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031: https://www.factmr.com/report/computer-assisted-orthopedic-surgery-market

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Mahendra Singh
Fact.MR
+1 6282511583
email us here


Source: EIN Presswire

Therap's E-Tools for Special Education, Student Profile and Family Information in human and community based settings

WATERBURY, CONNECTICUT, UNITED STATES, October 20, 2021 /EINPresswire.com/ — Therap's SPED documentation e-tools capture information about a student in a detailed Individual Demographic Form (IDF). The IDF has pictures, vital information, information about any dietary or other care requirements and detailed contact information about the student's relatives and legal contacts.

Therap's Case Management (CM) e-tools are structured documentation notes that can be modified by the school to capture, parent, relative, caregiver and student interviews and reviews. Therap's CM notes are structured as templates with options for time of service, service, activity type, location, face to face or other types of contact, the person contacted, attaching documents, and freeform CM Notes. A unique feature that can also be added to CM documentation records is a user defined questionnaire. The questionnaire can be developed by the organization or developed from a standard evaluation instrument. Both CM and Questionnaires are maintained in the system and can be used for individual or aggregate reporting.

Therap's Individual Support Plan Agenda (IEP Agenda) tracks meeting, review periods, and identified goals and strategies. The IEP identifies broad goals and detailed short-term objectives. Each ISP has a task or set of tasks and a scoring methodology. It can be used in the classroom to track and score the delivery of a structured curriculum. In addition to tracking daily performance the ISP serves as one of the essential elements for developing future IEPs. With Therap, the time-consuming assessment of tracking, scoring, and assessing each individual service is done in real time and the scores for each service can be linked to sophisticated reporting tools.

Therap's Special Education documentation e-tools are a Commercial Off the Shelf (COTS) product on a Software as a Service (SaaS) platform with state of the industry case load and role-based security. As a COTS and SaaS system bundled with full-service training and support system implementation can begin immediately upon signing a usage agreement using standard laptops, desktop, tablets or other technology with standard browsers (Chrome, Internet Explorer, etc.).

For more information on Therap's Electronic Tools for Special Education go to https://www.therapservices.net/products/electronic-solutions-for-special-education/

About Therap
Therap's comprehensive and HIPAA-compliant software is used in human services settings for documentation, communication, reporting, EVV and billing.

Learn more at www.therapservices.net.

Related Links
http://www.therapservices.net

Michelle Saunders
Therap Services LLC
+1 3127200305
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

IMRIS, Deerfield Imaging Receives FDA Clearance for the iMRI 3T-V Surgical System

IMRIS Logo

The Next Generation of Intraoperative MRI Technology

As the global leader of intraoperative imaging solutions, we bring better outcomes to patients, optimized workflow to surgeons and maximum value to hospitals.”

— IMRIS, Deerfield Imaging

MINNEAPOLIS, MINNESOTA, UNITED STATES, October 20, 2021 /EINPresswire.com/ — IMRIS, Deerfield Imaging, the global leader in intraoperative imaging, announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new iMRI 3T-V Surgical System, a multifunctional surgical environment designed to deliver unmatched intraoperative vision for clinicians, assist in surgical decision-making and enhance precision in treatment.

This newest imaging technology, based on Siemens MAGNETOM Vida, provides improved imaging speed, image quality and efficiency of scan acquisition by minimizing motion artifacts and sedation/anesthesia times thus decreasing the time to results. The new system utilizes Siemens BioMatrix 3T Technology that adapts to patient differences, reducing exam variations and rescans while enhancing results.

The IMRIS iMRI 3T-V Surgical Theatre, which was FDA cleared with our patented magnet mover technology, is available in a two-room or three-room configuration and features a 3 Tesla high-field MR scanner that will travel into the operating room on demand. This will provide intraoperative images of diagnostic quality without moving the patient and thereby minimizing associated risks. Clinicians will have access to real-time information while optimal surgical access and techniques are preserved. With integrated tools and technology designed specifically for neurosurgical applications, the IMRIS Surgical Theatre will allow optimal patient positioning for use of intraoperative MRI. Once positioned, it is unlikely the patient will ever need to be moved for scanning – before, during or after a procedure. Our patented ceiling-mounted rail system, the IMRIS Magnet Mover, is truly a one-of-a-kind innovation.

About IMRIS, Deerfield Imaging:
As a leader in image guided therapy solutions, IMRIS provides optimized fully integrated image-guided therapy environments that serve to address the important needs of patients, clinicians and hospitals by delivering timely information on surgical targets and results to clinicians for use during surgical or interventional procedures. The IMRIS Surgical Theatre incorporates MRI, CT and angiography into multi-purpose surgical suites to provide advanced intraoperative imaging directly in operating rooms. With a unique symphony of engineering and advanced imaging technology, the IMRIS Surgical Theatre is built for the human experience and inspired by the human mind – each IMRIS Surgical Theatre is custom-developed for the hospital and surgeons to uniquely compliment their workflow and intended use. IMRIS also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment. Products are sold globally to hospitals in the neurosurgical, spinal, cardiovascular, and orthopedic markets.

For more information, please visit www.imris.com.

Chelsey Wentz
IMRIS, Deerfield Imaging
+1 763-203-6432
cwentz@imris.com
Visit us on social media:
LinkedIn
Facebook
Twitter


Source: EIN Presswire

Plasma Fractionation Market Statistics 2021: Ready to Experience Exponential Hike by 2027

Allied Market Research - Logo

Allied Market Research – Logo

Rise in use of immunoglobulins in medicine, and emergence of plasma collection centers in different countries fuel the growth of the global plasma fractionation market.”

— Allied Market Research

PORTLAND, OR, UNITED STATES, October 20, 2021 /EINPresswire.com/ — Increase in geriatric population across the world, surge in the incidence of rare diseases, rise in use of immunoglobulins in medicine, and emergence of plasma collection centers in different countries fuel the growth of the global plasma fractionation market. On the other hand, high cost of plasma derived products impedes the growth to some extent. Nevertheless, high growth potential in emerging economies is expected to pave the way for lucrative opportunities for the frontrunners in the industry.

global Plasma Fractionation Market was estimated at $18.22 billion in 2019 and is expected to hit $23.00 billion by 2027, registering a CAGR of 6.2% from 2020 to 2027. The report provides an all-inclusive analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.

Explore Report Description@ https://www.alliedmarketresearch.com/plasma-fractionation-market

Covid-19 scenario-

– The outbreak of covid-19 led to postponements of planned surgeries across the world. Cases of hospital admission were also declined substantially. This factor affected the global plasma fractionation market.

– Simultaneously, the pandemic has also given way to a steep decline in the count of blood donations and plasma collections.

The global plasma fractionation market is analyzed across product, sector, and region. On the basis of product, the immunoglobulin segment contributed to around two-thirds of the total market share in 2019 and is anticipated to dominate by 2027. The albumin segment, on the other hand, would register the fastest CAGR of 6.3% during the forecast period.

On the basis of sector, the private sector accounted for more than three-fifths of the total market revenue in 2019 and is projected to retain its dominance throughout the forecast period. The same sector would also cite the fastest CAGR of 6.4% by the end of 2027.

Based on region, North America generated the major share in 2019, garnering around half of the global plasma fractionation market. Simultaneously, the region across Asia-Pacific would exhibit the fastest CAGR of 6.6% from 2020 to 2027. The other two provinces covered in the report include Europe and LAMEA.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/943

The key market players analyzed in the global plasma fractionation market report include Bio product laboratory, Biotest AG, Takeda Pharmaceutical Company Limited, CSL Ltd., Grifols SA, Kedrion S.P.A (Kedrion Biopharma Inc.), LFB S. A., Octapharma AG, Baxter International Inc., and Sanquin Blood Supply Foundation. These market players have taken recourse to several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their bent in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Closed MRI Systems Market Global Research By 2030

Cleanroom Technology Market Global Research By 2030

Patient Handling Equipment Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

AI in Medicine Market Rising Expeditiously Due to Advancement in AI Technology – Opportunities for Global Investors

Artificial intelligence in medicine market

Artificial intelligence in medicine market

Different interventions that range from identification of patients and maintenance of their records during clinical trials, to application in drug discovery and repurposing are gradually incorporating”

— Allied Market Research

PORTLAND, OR, UNITED STATES, October 20, 2021 /EINPresswire.com/ — In the field of medicine, artificial intelligence (AI) can be used for research studies and applications that support decision-based medical tasks using data-intensive computer-based solutions. For every drug that is launched in the market, the pharmaceutical industry spends on an average $2.7 billion, which amortizes the losses incurred from the aborted pipelines. Almost 90% of all drug programs that reach clinical trial stages are aborted. Thus, many large pharma and academic research institutions are focusing on use of AI to increase efficiencies and design better drugs.

Artificial Intelligence in Medicine Market by Product Type, Technology, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. North America was the highest contributor to the artificial intelligence in medicine market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period.

Explore Report Description@ https://www.alliedmarketresearch.com/artificial-intelligence-in-medicine-market

The major factors that drive the growth of the AI in medicine market include shortage of skilled healthcare professionals, the growth in importance of precision medicine, and increase in the processing power of AI systems that is estimated to help improve the efficiency of drug discovery and management of clinical trials. However, limited acceptance from healthcare professionals and limitations of AI decision-making limit the market growth. Conversely, the untapped market potential in developing regions such as India and China is anticipated to provide numerous opportunities for the market growth during the forecast period.

Among the technology segments, the natural language processing segment accounted for the highest share in 2017 and is expected to dominate the market from 2017 to 2023. The deep learning segment is projected to grow at the highest CAGR during the forecast period, owing to increase in use of signal reduction, data mining, and image recognition, which are integral components of most AI protocols.

Among the product type, the software segment occupied the highest share in 2017, owing to continuous software innovation that caters to the requirement in the healthcare sector. The hardware segment is projected to witness the highest growth rate during the forecast period.

Based on region, North America occupied the largest share in 2017 owing to availability of capital investments for use of AI in drug discovery and increase in adoption of AI technology by the pharmaceutical and biotechnology companies. However, Asia-Pacific is expected to grow at the highest CAGR of 55.0% during the study period, due to growth in healthcare expenditure, rise in the R&D activities for advancement in AI technology, lack of healthcare professionals, and increase in need to reduce the healthcare costs.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4749

The key players operating in the global artificial intelligence in medicine market include Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, and Berg Health.

Other prominent players in the value chain include InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Hearing Aids Market Global Research By 2030

Single Cell Analysis Market Global Research By 2030

Prostate Cancer Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire